Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$705,979
+$51,482 QoQ
Shares Held
5,494
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2,412
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $8,063,885 across 15 Drug Manufacturers - General names. MRK ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,004 | $2,265,766 | |
| 2 | JNJ |
Johnson & Johnson
|
7,699 | $1,955,315 | |
| 3 | NVS |
Novartis AG
|
6,281 | $984,358 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
5,494 | $705,979 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,283 | $541,114 | |
| 6 | LLY |
ELI LILLY & Co
|
450 | $539,743 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,281 | $304,291 | |
| 8 | AMGN |
Amgen Inc
|
657 | $237,912 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $705,979 | 5,494 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $654,497 | 5,441 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $604,192 | 5,740 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $477,981 | 5,695 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $450,816 | 5,695 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $511,183 | 5,695 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $566,538 | 5,695 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $657,285 | 5,788 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $722,496 | 5,836 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $796,450 | 6,036 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $695,656 | 6,381 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $656,512 | 6,377 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $741,149 | 6,423 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $678,023 | 6,373 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $760,229 | 6,852 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $702,308 | 8,155 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $766,010 | 8,402 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $703,332 | 8,572 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $675,888 | 8,819 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $640,162 | 8,523 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $601,395 | 7,733 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $494,532 | 6,415 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $415,053 | 5,074 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $413,340 | 4,983 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $388,660 | 5,026 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $382,853 | 4,976 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||